Tekla Life Sciences Investors | Financial Services
Dividend King
Market Cap:497.26M
ℹ️
Reward Rating
68
High
Top 25% (model universe)
75% data coverage
ℹ️
Risk Rating
22
Low
Risk Assessment
ℹ️
Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.
We don't have enough public data on HQL to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.
Market Performance
Stock returned +10.0% over the past year, broadly in line with market conditions.
What is Tekla Life Sciences Investors?
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc.
HQL · Verdict
Solid reward · low risk
HQL scores well on balance sheet and growth with no major weaknesses flagged in the model.
Based on 88% data coverage
HQL · Verdict
What’s working & what to watch
Strengths 5
Balance sheet94/100
Current ratio 1.74
Growth85/100
Top decile vs peers
Cash flow84/100
37% free-cash-flow margin
Profitability69/100
99% net margin · 18% ROE
Volatility65/100
Above average
No major weaknesses flagged.
Model-based scoring. For information only — not financial advice.
What is Tekla Life Sciences Investors?
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. The company is listed on the NYSE in USA, operating in the Financial Services sector, with a market capitalisation of 497.26M, and a P/E ratio of 6.0x.
Financial Highlights
Investment Breakdown
📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation appears fair relative to current fundamentals.
Analysis
Reward: High (68)
The scoring profile indicates moderate reward potential, with growth and profitability as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.